Welcome to LookChem.com Sign In|Join Free
  • or
1-[1-(1H-indol-3-yl)methyl]-1H-indole is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

858232-12-9

Post Buying Request

858232-12-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

858232-12-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 858232-12-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,2,3 and 2 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 858232-12:
(8*8)+(7*5)+(6*8)+(5*2)+(4*3)+(3*2)+(2*1)+(1*2)=179
179 % 10 = 9
So 858232-12-9 is a valid CAS Registry Number.

858232-12-9Relevant academic research and scientific papers

Solvent-Free addition of indole to aldehydes: Unexpected synthesis of novel 1-[1-(1h-indol-3-yl) alkyl]-1h-indoles and preliminary evaluation of their cytotoxicity in hepatocarcinoma cells

Tocco, Graziella,Zedda, Gloria,Casu, Mariano,Simbula, Gabriella,Begala, Michela

, (2017)

New 1-[1-(1H-indol-3-yl) alkyl]-1H-indoles, surprisingly, have been obtained from the addition of indole to a variety of aldehydes under neat conditions. CaO, present in excess, was fundamental for carrying out the reaction with paraformaldehyde. Under the same reaction conditions, aromatic and heteroaromatic aldehydes afforded only classical bis (indolyl) aryl indoles. In this paper, the role of CaO, together with the regiochemistry and the mechanism of the reaction, are discussed in detail. The effect of some selected 3,3'- and 1,3'-diindolyl methane derivatives on cell proliferation of the hepatoma cell line FaO was also evaluated.

TREATMENT OF PROTEIN FOLDING DISORDERS

-

Page/Page column 79-80, (2010/11/25)

In certain embodiments, the invention is directed to a method for treating a protein folding disorder such as Alzheimer's disease, dementia, Parkinson's disease, Huntington's disease and prion-based spongiform encephalopathy. The method comprises the administration to a subject of a compound of the formula (I) wherein A and B are independently a mono- or bicyclic aromatic group or heteroaromatic cyclic group. In preferred embodiments, the compounds are bis-indole compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 858232-12-9